Expanding Product Portfolio IDT's recent launches of specialized tools such as UncoverSeq, PrimeTime Influenza Kit, and Alt-R HDR Enhancer Protein indicate a focus on expanding their product offerings in genome editing, pathogen detection, and targeted research. These developments present opportunities to cross-sell complementary biotech reagents and support services to laboratories engaged in advanced genetic and infectious disease research.

Strategic Facility Expansion The company's investment in new facilities in California demonstrates a commitment to regional growth and innovation in the biotech sector. This expansion can be leveraged to target biotech clusters and research institutions in key geographic areas, offering tailored laboratory solutions, collaborations, and localized support to accelerate sales efforts.

Strong R&D Focus IDT's integration of advanced technologies like Anchored Multiplex PCR (AMP™) and partnerships with AI-driven companies like Profluent Bio highlight a focus on cutting-edge research tools. Sales opportunities exist in providing custom assay development, high-throughput sequencing reagents, and AI-enabled genomics solutions to institutions involved in precision medicine and cancer research.